These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23507476)

  • 1. ALCAM--novel multiple sclerosis locus interfering with HLA-DRB1*1501.
    Wagner M; Wiśniewski A; Bilińska M; Pokryszko-Dragan A; Nowak I; Kuśnierczyk P; Jasek M
    J Neuroimmunol; 2013 May; 258(1-2):71-6. PubMed ID: 23507476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ALCAM and CD6--multiple sclerosis risk factors.
    Wagner M; Bilinska M; Pokryszko-Dragan A; Sobczynski M; Cyrul M; Kusnierczyk P; Jasek M
    J Neuroimmunol; 2014 Nov; 276(1-2):98-103. PubMed ID: 25216742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between HLA-DRB1* 11/15 genotype and susceptibility to multiple sclerosis in Iran.
    Abolfazli R; Samadzadeh S; Sabokbar T; Siroos B; Armaki SA; Aslanbeiki B; Ghelman M; Taheri T; Shakoori A
    J Neurol Sci; 2014 Oct; 345(1-2):92-6. PubMed ID: 25064442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contributions of vitamin D response elements and HLA promoters to multiple sclerosis risk.
    Nolan D; Castley A; Tschochner M; James I; Qiu W; Sayer D; Christiansen FT; Witt C; Mastaglia F; Carroll W; Kermode A
    Neurology; 2012 Aug; 79(6):538-46. PubMed ID: 22786591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of HLA-DRB1*1501 allele and TNF-alpha -308 G/A single nucleotide polymorphism in the susceptibility to multiple sclerosis.
    Shahbazi M; Roshandel D; Omidnyia E; Rshaidbaghan A
    Clin Immunol; 2011 Jun; 139(3):277-81. PubMed ID: 21396892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The +190 G/A (rs1799864) polymorphism in the C-C chemokine receptor 2 (CCR2) gene is associated with susceptibility to multiple sclerosis in HLA-DRB1*15:01-negative individuals.
    Javor J; Párnická Z; Michalik J; Čopíková-Cudráková D; Shawkatová I; Ďurmanová V; Gmitterová K; Klímová E; Bucová M; Buc M
    J Neurol Sci; 2015 Feb; 349(1-2):138-42. PubMed ID: 25604634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome wide differences of gene expression associated with HLA-DRB1 genotype in multiple sclerosis: a pilot study.
    Apperson ML; Tian Y; Stamova B; Ander BP; Jickling GC; Agius MA; Sharp FR
    J Neuroimmunol; 2013 Apr; 257(1-2):90-6. PubMed ID: 23477965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between HLA-DRB1 alleles and optic neuritis in Irish patients and the risk of developing multiple sclerosis.
    Tuwir I; Dunne C; Crowley J; Saddik T; Murphy R; Cassidy L
    Br J Ophthalmol; 2007 Oct; 91(10):1288-92. PubMed ID: 17895416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of Myelin Basic Protein Gene Polymorphisms with HLA-DRB1*1501 in Iranian Patients with Multiple Sclerosis.
    Nejati P; Attar M; Rahimian M; Fathi D; Shahbazi M
    Iran J Immunol; 2017 Sep; 14(3):231-239. PubMed ID: 28919586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA associations with multiple sclerosis in Greece.
    Kouri I; Papakonstantinou S; Bempes V; Vasiliadis HS; Kyritsis AP; Pelidou SH
    J Neurol Sci; 2011 Sep; 308(1-2):28-31. PubMed ID: 21741664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DRB1*15:01 and multiple sclerosis: a female association?
    Irizar H; Muñoz-Culla M; Zuriarrain O; Goyenechea E; Castillo-Triviño T; Prada A; Saenz-Cuesta M; De Juan D; Lopez de Munain A; Olascoaga J; Otaegui D
    Mult Scler; 2012 May; 18(5):569-77. PubMed ID: 22127897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sclerosis risk genotypes correlate with an elevated cerebrospinal fluid level of the suggested prognostic marker CXCL13.
    Lindén M; Khademi M; Lima Bomfim I; Piehl F; Jagodic M; Kockum I; Olsson T
    Mult Scler; 2013 Jun; 19(7):863-70. PubMed ID: 23175382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple sclerosis risk markers in HLA-DRA, HLA-C, and IFNG genes are associated with sex-specific childhood leukemia risk.
    Morrison BA; Ucisik-Akkaya E; Flores H; Alaez C; Gorodezky C; Dorak MT
    Autoimmunity; 2010 Dec; 43(8):690-7. PubMed ID: 21067287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA (A-B-C and -DRB1) alleles and brain MRI changes in multiple sclerosis: a longitudinal study.
    Liguori M; Healy BC; Glanz BI; Khoury SJ; Moscufo N; Weiner HL; De Jager PL; Guttmann CR
    Genes Immun; 2011 Apr; 12(3):183-90. PubMed ID: 21179117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of combined genotypes of the HLADRB1*1501 and CD24 single nucleotide polymorphism on disease severity of Iranian multiple sclerosis patients.
    Ghlichnia HA; Kollaee A; Gaffarpoor M; Movafagh A; Ghlichnia B; Zamani M
    Acta Med Iran; 2014; 52(6):418-23. PubMed ID: 25130147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential association of vitamin D receptor polymorphism Taq1 with multiple sclerosis.
    Cox MB; Ban M; Bowden NA; Baker A; Scott RJ; Lechner-Scott J
    Mult Scler; 2012 Jan; 18(1):16-22. PubMed ID: 21816760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A NOTCH4 missense mutation confers resistance to multiple sclerosis in Japanese.
    Huang J; Yoshimura S; Isobe N; Matsushita T; Yonekawa T; Sato S; Yamasaki R; Kira J;
    Mult Scler; 2013 Nov; 19(13):1696-703. PubMed ID: 23549433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.
    Barcellos LF; Sawcer S; Ramsay PP; Baranzini SE; Thomson G; Briggs F; Cree BC; Begovich AB; Villoslada P; Montalban X; Uccelli A; Savettieri G; Lincoln RR; DeLoa C; Haines JL; Pericak-Vance MA; Compston A; Hauser SL; Oksenberg JR
    Hum Mol Genet; 2006 Sep; 15(18):2813-24. PubMed ID: 16905561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis.
    Stankovich J; Butzkueven H; Marriott M; Chapman C; Tubridy N; Tait BD; Varney MD; Taylor BV; Foote SJ; ; Kilpatrick TJ; Rubio JP
    Tissue Antigens; 2009 Jul; 74(1):17-21. PubMed ID: 19392788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variation in ALCAM and other chromosomal instability genes in breast cancer survival.
    Varadi V; Bevier M; Grzybowska E; Johansson R; Enquist-Olsson K; Henriksson R; Butkiewicz D; Pamula-Pilat J; Tecza K; Hemminki K; Lenner P; Försti A
    Breast Cancer Res Treat; 2012 Jan; 131(1):311-9. PubMed ID: 21935604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.